{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T01:39:21Z","timestamp":1742953161331,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":10,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493940097"},{"type":"electronic","value":"9781493940110"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-4011-0_3","type":"book-chapter","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T00:40:51Z","timestamp":1472604051000},"page":"27-35","source":"Crossref","is-referenced-by-count":0,"title":["CML Mouse Model Generated from Leukemia Stem Cells"],"prefix":"10.1007","author":[{"given":"Yiguo","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"key":"3_CR1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/0003-4819-138-10-200305200-00010","volume":"138","author":"R Kurzrock","year":"2003","unstructured":"Kurzrock R, Kantarjian HM, Druker BJ, Talpaz M (2003) Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann Intern Med 138:819\u2013830","journal-title":"Ann Intern Med"},{"key":"3_CR2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1172\/JCI109193","volume":"62","author":"PJ Fialkow","year":"1978","unstructured":"Fialkow PJ, Denman AM, Jacobson RJ, Lowenthal MN (1978) Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest 62:815\u2013823","journal-title":"J Clin Invest"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc3317","volume":"12","author":"T O\u2019Hare","year":"2012","unstructured":"O\u2019Hare T, Zabriskie MS, Eiring AM, Deininger MW (2012) Pushing the limits of targeted therapy in chronic myeloid leukaemia. Nat Rev Cancer 12:513\u2013526","journal-title":"Nat Rev Cancer"},{"key":"3_CR4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcancer.2009.12.001","volume":"20","author":"SW Lane","year":"2010","unstructured":"Lane SW, Gilliland DG (2010) Leukemia stem cells. Semin Cancer Biol 20:71\u201376","journal-title":"Semin Cancer Biol"},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"16870","DOI":"10.1073\/pnas.0606509103","volume":"103","author":"Y Hu","year":"2006","unstructured":"Hu Y, Swerdlow S, Duffy TM, Weinmann R, Lee FY, Li S (2006) Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph\u2009+\u2009leukemia in mice. Proc Natl Acad Sci U S A 103:16870\u201316875","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.leu.2403649","volume":"19","author":"W Eisterer","year":"2005","unstructured":"Eisterer W, Jiang X, Christ O, Glimm H, Lee KH, Pang E, Lambie K, Shaw G, Holyoake TL, Petzer AL, Auewarakul C, Barnett MJ, Eaves CJ, Eaves AC (2005) Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease. Leukemia 19:435\u2013441","journal-title":"Leukemia"},{"key":"3_CR7","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1073\/pnas.94.10.5320","volume":"94","author":"M Bhatia","year":"1997","unstructured":"Bhatia M, Wang JC, Kapp U, Bonnet D, Dick JE (1997) Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A 94:5320\u20135325","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR8","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","volume":"123","author":"H Herrmann","year":"2014","unstructured":"Herrmann H, Sadovnik I, Cerny-Reiterer S, Rulicke T, Stefanzl G, Willmann M, Hoermann G, Bilban M, Blatt K, Herndlhofer S, Mayerhofer M, Streubel B, Sperr WR, Holyoake TL, Mannhalter C, Valent P (2014) Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia. Blood 123:3951\u20133962","journal-title":"Blood"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11912-001-0055-y","volume":"3","author":"RA Etten Van","year":"2001","unstructured":"Van Etten RA (2001) Models of chronic myeloid leukemia. Curr Oncol Rep 3:228\u2013237","journal-title":"Curr Oncol Rep"},{"key":"3_CR10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.hoc.2004.03.003","volume":"18","author":"RL Ilaria Jr","year":"2004","unstructured":"Ilaria RL Jr (2004) Animal models of chronic myelogenous leukemia. Hematol Oncol Clin North Am 18:525\u2013543, vii","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["Methods in Molecular Biology","Chronic Myeloid Leukemia"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-4011-0_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:41:41Z","timestamp":1498326101000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-4011-0_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493940097","9781493940110"],"references-count":10,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-4011-0_3","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2016]]}}}